Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials
- Resource Type
- Journal
- Source
ONCOTARGET ; OCT 13 2017, 8 48, p84572-p84578, 7p.- Subject
- Language
- English
- ISSN
- 19492553